Effect of Small Molecule Vasopressin V 1a and V 2 Receptor Antagonists on Brain Edema Formation and Secondary Brain Damage following Traumatic Brain Injury in Mice
- 15 February 2015
- journal article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 32 (4) , 221-227
Abstract
The attenuation of brain edema is a major therapeutic target after traumatic brain injury (TBI). Vasopressin (AVP) is well known to play a major role in the regulation of brain water content and vasoendothelial functions and to be involved in brain edema formation. Therefore, the aim of the current study was to analyze the antiedematous efficacy of a clinically relevant, nonpeptidic AVP V 1a and V 2 receptor antagonists. C57Bl6 mice were subjected to controlled cortical impact (CCI) and V 1a or V 2 receptors were inhibited by using the highly selective antagonists SR-49059 or SR-121463A either by systemic (intraperitoneal, IP) or intracerebroventricular (ICV) application. After 24 h, brain edema, intracranial pressure (ICP), and contusion volume were assessed. Systemically applied AVP receptor antagonists could not reduce secondary lesion growth. In contrast, ICV administration of AVP V 1a receptor antagonist decreased brain edema formation by 68%, diminished post-traumatic increase of ICP by 46%, and reduced secondary contusion expansion by 43% 24 h after CCI. The ICV inhibition of V 2 receptors resulted in significant reduction of post-traumatic brain edema by 41% 24 h after CCI, but failed to show further influence on ICP and lesion growth. Hence, centrally applied vasopressin V 1a receptor antagonists may be used to reduce brain edema formation after TBI.Keywords
This publication has 50 references indexed in Scilit:
- Vasopressin V 1a Receptors Mediate Posthemorrhagic Systemic Hypertension Thereby Determining Rebleeding Rate and Outcome After Experimental Subarachnoid HemorrhageStroke, 2012
- Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injuryNeurochemistry International, 2011
- The Epidemiology of Traumatic Brain InjuryJournal of Head Trauma Rehabilitation, 2010
- Role of Vasopressin V 1a and V 2 Receptors for the Development of Secondary Brain Damage after Traumatic Brain Injury in MiceJournal of Neurotrauma, 2008
- Arterial hypotension triggers perifocal depolarizations and aggravates secondary damage in focal brain injuryBrain Research, 2006
- Neuronal death after brain injuryCell and tissue research, 1999
- Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.Journal of Clinical Investigation, 1996
- Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brainDifferentiation, 1995
- Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.Stroke, 1992
- Effect of vasopressin on brain swelling at the cellular level: do astrocytes exhibit a furosernide–vasopressin-sensitive mechanism for volume regulation?Canadian Journal of Physiology and Pharmacology, 1992